| 1 |
Fraser R, Orta-Resendiz A, Dockrell D, Müller-Trutwin M, Mazein A. Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection. Eur Respir Rev 2023;32:220197. [PMID: 36889788 DOI: 10.1183/16000617.0197-2022] [Reference Citation Analysis]
|
| 2 |
Tsounis EP, Triantos C, Konstantakis C, Marangos M, Assimakopoulos SF. Intestinal barrier dysfunction as a key driver of severe COVID-19. World J Virol 2023; 12(2): 68-90 [DOI: 10.5501/wjv.v12.i2.68] [Reference Citation Analysis]
|
| 3 |
Niculae C, Hristea A, Moroti R. Mechanisms of COVID-19 Associated Pulmonary Thrombosis: A Narrative Review. Biomedicines 2023;11:929. [DOI: 10.3390/biomedicines11030929] [Reference Citation Analysis]
|
| 4 |
Miggiolaro AFRS, da Silva FPG, Wiedmer DB, Godoy TM, Borges NH, Piper GW, Oricil AGG, Klein CK, Hlatchuk EC, Dagostini JCH, Collete M, Arantes MP, D’amico RC, Dutra AA, de Azevedo MLV, de Noronha L. COVID-19 and Pulmonary Angiogenesis: The Possible Role of Hypoxia and Hyperinflammation in the Overexpression of Proteins Involved in Alveolar Vascular Dysfunction. Viruses 2023;15:706. [DOI: 10.3390/v15030706] [Reference Citation Analysis]
|
| 5 |
Augustine Anayochukwu Onyeaghala, Arinze Favour Anyiam, Danladi Chiroma Husaini, Emmanuella Ogechi Onyeaghala, Ejeatuluchukwu Obi. Herbal Supplements as Treatment Options for COVID-19: A call for Clinical Development of Herbal Supplements for Emerging and Re-Emerging Viral Threats in Sub-Saharan Africa. Sci Afr 2023:e01627. [ DOI: 10.1016/j.sciaf.2023.e01627] [Reference Citation Analysis]
|
| 6 |
La Torre G, Nagra R, Wijesinghe H, Rajeswaran G, Riya J, Abdulkhaliq S, Barker T, Ganeshan A, Goudie R, Hosaam N, Tiwari A, Juszczak MT. Prevalence of venous thromboembolism in patients undergoing diagnostic venous ultrasound during the first SARS-CoV-2 pandemic. Vasa 2023;52:97-106. [PMID: 36660828 DOI: 10.1024/0301-1526/a001052] [Reference Citation Analysis]
|
| 7 |
Marcos-Jubilar M, Lecumberri R, Páramo JA. Immunothrombosis: Molecular Aspects and New Therapeutic Perspectives. J Clin Med 2023;12. [PMID: 36835934 DOI: 10.3390/jcm12041399] [Reference Citation Analysis]
|
| 8 |
Yiang GT, Wu YK, Tsai KW, Tzeng IS, Hu WC, Liao MT, Lu KC, Chung HW, Chao YC, Su WL. Immunothrombosis biomarkers as potential predictive factors of acute respiratory distress syndrome in moderate-to-critical COVID-19: A single-center, retrospective cohort study. Immunol Lett 2023;254:30-8. [PMID: 36702261 DOI: 10.1016/j.imlet.2023.01.010] [Reference Citation Analysis]
|
| 9 |
Buso G, Mazzolai L, Rueda-Camino JA, Fernández-Capitán C, Jiménez D, Bikdeli B, Lobo JL, Fernández-Reyes JL, Ciammaichella M, Monreal M; RIETE Investigators. Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings. Semin Thromb Hemost 2023;49:34-46. [PMID: 34902865 DOI: 10.1055/s-0041-1740152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 10 |
Yamashita A, Asada Y. Underlying mechanisms of thrombus formation/growth in atherothrombosis and deep vein thrombosis. Pathol Int 2023;73:65-80. [PMID: 36598039 DOI: 10.1111/pin.13305] [Reference Citation Analysis]
|
| 11 |
Goudswaard LJ, Williams CM, Khalil J, Burley KL, Hamilton F, Arnold D, Milne A, Lewis PA, Heesom KJ, Mundell SJ, Davidson AD, Poole AW, Hers I. Alterations in platelet proteome signature and impaired platelet integrin α(IIb)β(3) activation in patients with COVID-19. J Thromb Haemost 2023:S1538-7836(23)00059-4. [PMID: 36716966 DOI: 10.1016/j.jtha.2023.01.018] [Reference Citation Analysis]
|
| 12 |
Wan EYF, Mathur S, Zhang R, Yan VKC, Lai FTT, Chui CSL, Li X, Wong CKH, Chan EWY, Yiu KH, Wong ICK. Association of COVID-19 with short- and long-term risk of cardiovascular disease and mortality: a prospective cohort in UK Biobank. Cardiovasc Res 2023:cvac195. [PMID: 36652991 DOI: 10.1093/cvr/cvac195] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 13 |
Narwal A, Whyte CS, Mutch NJ. Location, location, location: Fibrin, cells, and fibrinolytic factors in thrombi. Front Cardiovasc Med 2022;9:1070502. [PMID: 36741833 DOI: 10.3389/fcvm.2022.1070502] [Reference Citation Analysis]
|
| 14 |
Gaughan EE, Quinn TM, Mills A, Bruce AM, Antonelli J, MacKinnon AC, Aslanis V, Li F, O'Connor R, Boz C, Mills R, Emanuel P, Burgess M, Rinaldi G, Valanciute A, Mills B, Scholefield E, Hardisty G, Findlay EG, Parker RA, Norrie J, Dear JW, Akram AR, Koch O, Templeton K, Dockrell DH, Walsh TS, Partridge S, Humphries D, Wang-Jairaj J, Slack RJ, Schambye H, Phung D, Gravelle L, Lindmark B, Shankar-Hari M, Hirani N, Sethi T, Dhaliwal K. An Inhaled Galectin-3 Inhibitor in COVID-19 Pneumonitis: A Phase Ib/IIa Randomized Controlled Clinical Trial (DEFINE). Am J Respir Crit Care Med 2023;207:138-49. [PMID: 35972987 DOI: 10.1164/rccm.202203-0477OC] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Nickl R, Hauser S, Pietzsch J, Richter T. Significance of Pulmonary Endothelial Injury and the Role of Cyclooxygenase-2 and Prostanoid Signaling. Bioengineering (Basel) 2023;10. [PMID: 36671689 DOI: 10.3390/bioengineering10010117] [Reference Citation Analysis]
|
| 16 |
Induruwa I, Cattermole E, Paisey C, Ne CKH, Khadjooi K. Higher incidence of new atrial fibrillation in hospitalised COVID-19 patients compared to lower respiratory tract infection, however, less patients anticoagulated at discharge.. [DOI: 10.21203/rs.3.rs-2458970/v1] [Reference Citation Analysis]
|
| 17 |
Singh M, Pushpakumar S, Bard N, Zheng Y, Homme RP, Mokshagundam SPL, Tyagi SC. Simulation of COVID-19 symptoms in a genetically engineered mouse model: implications for the long haulers. Mol Cell Biochem 2023;478:103-19. [PMID: 35731343 DOI: 10.1007/s11010-022-04487-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Yoon SM, Lee J, Lee SM, Lee HY. Incidence and clinical outcomes of bacterial superinfections in critically ill patients with COVID-19. Front Med (Lausanne) 2023;10:1079721. [PMID: 36936237 DOI: 10.3389/fmed.2023.1079721] [Reference Citation Analysis]
|
| 19 |
Donkin R, Fung YL, Singh I. Fibrinogen, Coagulation, and Ageing. Subcell Biochem 2023;102:313-42. [PMID: 36600138 DOI: 10.1007/978-3-031-21410-3_12] [Reference Citation Analysis]
|
| 20 |
Li C, Li Y, Zhang H, Zhuo Y, Zhang L, Yang L, Gao Q, Tu Z, Shao R, Wang Y, Zhang J, Cui L, Zhang S. Xuanfei Baidu Decoction suppresses complement overactivation and ameliorates IgG immune complex-induced acute lung injury by inhibiting JAK2/STAT3/SOCS3 and NF-κB signaling pathway. Phytomedicine 2023;109:154551. [PMID: 36610119 DOI: 10.1016/j.phymed.2022.154551] [Reference Citation Analysis]
|
| 21 |
Luu IHY, Frijns T, Buijs J, Krdzalic J, de Kruif MD, Mostard GJM, Ten Cate H, Martens RJH, Mostard RLM, Leers MPG, van Twist DJL. Systematic screening versus clinical gestalt in the diagnosis of pulmonary embolism in COVID-19 patients in the emergency department. PLoS One 2023;18:e0283459. [PMID: 36952456 DOI: 10.1371/journal.pone.0283459] [Reference Citation Analysis]
|
| 22 |
Yu C. Lessons from the contrast dye shortage during COVID-19: A narrative review. Medicine (Baltimore) 2022;101:e32286. [PMID: 36595743 DOI: 10.1097/MD.0000000000032286] [Reference Citation Analysis]
|
| 23 |
Mirabootalebi FS, Hoseinpour Moghadam M, Kazemi MH, Shekarriz-foumani R, Najafizadeh K, Hajifathali A, Ghafouri R, Pirsalehi A, Amin R, Akhlaghi SS. Association of Clinical and Laboratory Findings in COVID-19 Patients with Thromboembolic Complications. Jundishapur J Microbiol 2022;15. [DOI: 10.5812/jjm-130805] [Reference Citation Analysis]
|
| 24 |
Devalaraja-Narashimha K, Ehmann PJ, Huang C, Ruan Q, Wipperman MF, Kaplan T, Liu C, Afolayan S, Glass D, Mellis S, Yancopoulos GD, Hamilton JD, MacDonnell S, Hamon SC, Boyapati A, Morton L. Association of complement pathways with COVID-19 severity and outcomes. Microbes Infect 2022;:105081. [PMID: 36494054 DOI: 10.1016/j.micinf.2022.105081] [Reference Citation Analysis]
|
| 25 |
Singh J, Herrmann I, Mahajan A, Schauer C, Shan X, Hartmann A, Rieker RJ, Evert K, Falkeis C, Naschberger E, von Stillfried S, Boor P, Muñoz LE, Schett G, Herrmann M, Knopf J. A Pleomorphic Puzzle: Heterogeneous Pulmonary Vascular Occlusions in Patients with COVID-19. Int J Mol Sci 2022;23. [PMID: 36499449 DOI: 10.3390/ijms232315126] [Reference Citation Analysis]
|
| 26 |
Hönzke K, Obermayer B, Mache C, Fathykova D, Kessler M, Dökel S, Wyler E, Baumgardt M, Löwa A, Hoffmann K, Graff P, Schulze J, Mieth M, Hellwig K, Demir Z, Biere B, Brunotte L, Mecate-Zambrano A, Bushe J, Dohmen M, Hinze C, Elezkurtaj S, Tönnies M, Bauer TT, Eggeling S, Tran HL, Schneider P, Neudecker J, Rückert JC, Schmidt-Ott KM, Busch J, Klauschen F, Horst D, Radbruch H, Radke J, Heppner F, Corman VM, Niemeyer D, Müller MA, Goffinet C, Mothes R, Pascual-Reguant A, Hauser AE, Beule D, Landthaler M, Ludwig S, Suttorp N, Witzenrath M, Gruber AD, Drosten C, Sander LE, Wolff T, Hippenstiel S, Hocke AC. Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages. Eur Respir J 2022;60. [PMID: 35728978 DOI: 10.1183/13993003.02725-2021] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 27 |
Sugimoto MA, Perucci LO, Tavares LP, Teixeira MM, Sousa LP. Fibrinolysis in COVID-19: Impact on Clot Lysis and Modulation of Inflammation. Curr Drug Targets 2022;23:1578-92. [PMID: 36221881 DOI: 10.2174/1389450123666221011102250] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Lee WG. COVID-19 and priapism: An unexplored association. Curr Urol 2022;16:265-6. [PMID: 36628403 DOI: 10.1097/CU9.0000000000000139] [Reference Citation Analysis]
|
| 29 |
Mortezaee K, Majidpoor J. Cellular immune states in SARS-CoV-2-induced disease. Front Immunol 2022;13:1016304. [PMID: 36505442 DOI: 10.3389/fimmu.2022.1016304] [Reference Citation Analysis]
|
| 30 |
Zekri-nechar K, Zamorano-león JJ, Reche C, Giner M, López-de-andrés A, Jiménez-garcía R, López-farré AJ, Martínez-martínez CH. Spike Protein Subunits of SARS-CoV-2 Alter Mitochondrial Metabolism in Human Pulmonary Microvascular Endothelial Cells: Involvement of Factor Xa. Disease Markers 2022;2022:1-11. [DOI: 10.1155/2022/1118195] [Reference Citation Analysis]
|
| 31 |
Bykov VV, Vengerovskii AI, Udut VV. The Relationship between Inflammation and Hemostasis Disorders in Cardiovascular and Infectious Diseases. Annals RAMS 2022;77:261-266. [DOI: 10.15690/vramn2124] [Reference Citation Analysis]
|
| 32 |
Grigoreva KN, Bitsadze VO, Khizroeva JK, Tsibizova VI, Tretyakova MV, Blinov DV, Pankratyeva LL, Gashimova NR, Yakubova FE, Antonova AS, Gris J, Elalamy I, Makatsariya AD. Prognostic value of von Willebrand factor in clinical practice. Akušerstvo, ginekologiâ i reprodukciâ 2022;16:588-599. [DOI: 10.17749/2313-7347/ob.gyn.rep.2022.363] [Reference Citation Analysis]
|
| 33 |
Kaiafa G, Savopoulos C, Karlafti E, Pantazi K, Paramythiotis D, Thomaidou E, Daios S, Ztriva E, Gionis M, Fyntanidou V, Argiriadou H, Didangelos T. Coagulation Profile of COVID-19 Patients. Life 2022;12:1658. [DOI: 10.3390/life12101658] [Reference Citation Analysis]
|
| 34 |
de Cossio S, Paredes-Ruiz D, Gómez-Cuervo C, González-Olmedo J, Lalueza A, Revilla Y, Lumbreras C, Díaz-Pedroche C. Clinical Differences and Outcomes of COVID-19 Associated Pulmonary Thromboembolism in Comparison with Non-COVID-19 Pulmonary Thromboembolism. J Clin Med 2022;11. [PMID: 36294331 DOI: 10.3390/jcm11206011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 35 |
Goudswaard LJ, Williams CM, Khalil J, Burley KL, Hamilton F, Arnold D, Milne A, Lewis PA, Heesom KJ, Mundell SJ, Davidson AD, Poole AW, Hers I. Alterations in platelet proteome signature and impaired platelet integrin αIIbβ3activation in patients with COVID-19.. [DOI: 10.1101/2022.10.12.511145] [Reference Citation Analysis]
|
| 36 |
Knight R, Walker V, Ip S, Cooper JA, Bolton T, Keene S, Denholm R, Akbari A, Abbasizanjani H, Torabi F, Omigie E, Hollings S, North TL, Toms R, Jiang X, Angelantonio ED, Denaxas S, Thygesen JH, Tomlinson C, Bray B, Smith CJ, Barber M, Khunti K, Davey Smith G, Chaturvedi N, Sudlow C, Whiteley WN, Wood AM, Sterne JAC; CVD-COVID-UK/COVID-IMPACT Consortium and the Longitudinal Health and Wellbeing COVID-19 National Core Study. Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales. Circulation 2022;146:892-906. [PMID: 36121907 DOI: 10.1161/CIRCULATIONAHA.122.060785] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 24.0] [Reference Citation Analysis]
|
| 37 |
Batiha GE, Al-gareeb AI, Elekhnawy E, Al-kuraishy HM. Potential role of lipoxin in the management of COVID-19: a narrative review. Inflammopharmacol. [DOI: 10.1007/s10787-022-01070-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 38 |
Wilkinson H, Leonard H, Robson MG, Smith R, Tam E, Mcvey JH, Kirckhofer D, Chen D, Dorling A. Manipulation of tissue factor-mediated basal PAR-2 signalling on macrophages determines sensitivity for IFNγ responsiveness and significantly modifies the phenotype of murine DTH. Front Immunol 2022;13:999871. [DOI: 10.3389/fimmu.2022.999871] [Reference Citation Analysis]
|
| 39 |
Dybowska M, Wyrostkiewicz D, Opoka L, Lewandowska K, Sobiecka M, Tomkowski W, Szturmowicz M. Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis. IJMS 2022;23:10372. [DOI: 10.3390/ijms231810372] [Reference Citation Analysis]
|
| 40 |
Franco-moreno A, Brown-lavalle D, Rodríguez-ramírez N, Muñoz-roldán C, Rubio-aguilera A, Campos-arenas M, Muñoz-rivas N, Moya-mateo E, Ruiz-giardín J, Pardo-guimerá V, Ulla-anes M, Pedrero-tomé R, Torres-macho J, Bustamante-fermosel A. Clinical prediction model for pulmonary embolism diagnosis in hospitalized patients with SARS-CoV-2 infection.. [DOI: 10.21203/rs.3.rs-2000969/v1] [Reference Citation Analysis]
|
| 41 |
Mortazavi-Jahromi SS, Aslani M. Dysregulated miRNAs network in the critical COVID-19: An important clue for uncontrolled immunothrombosis/thromboinflammation. Int Immunopharmacol 2022;110:109040. [PMID: 35839566 DOI: 10.1016/j.intimp.2022.109040] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 42 |
Rodriguez M, Dai W, Lund H, Osinski K, Zhang Z, Silverstein R, Zheng Z. The correlations among racial/ethnic groups, hypertriglyceridemia, thrombosis, and mortality in hospitalized patients with COVID-19. Best Pract Res Clin Haematol 2022;35:101386. [PMID: 36494155 DOI: 10.1016/j.beha.2022.101386] [Reference Citation Analysis]
|
| 43 |
Menale S, Scheggi V, Giovacchini J, Marchionni N. Persistent respiratory failure after SARS-CoV-2 infection: The role of dual energy computed tomography. A case report. Radiology Case Reports 2022;17:3179-3184. [DOI: 10.1016/j.radcr.2022.05.031] [Reference Citation Analysis]
|
| 44 |
Kell DB, Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J 2022;479:1653-708. [PMID: 36043493 DOI: 10.1042/BCJ20220154] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 45 |
Farrell J, Docherty AB, Thorpe MG, Shaw CA, Harrison EM, Lone NI. Twelve-month risk of thromboembolic events in COVID-19 hospital survivors in Scotland. Anaesthesia 2022. [PMID: 36000949 DOI: 10.1111/anae.15826] [Reference Citation Analysis]
|
| 46 |
Iwamura C, Hirahara K, Kiuchi M, Ikehara S, Azuma K, Shimada T, Kuriyama S, Ohki S, Yamamoto E, Inaba Y, Shiko Y, Aoki A, Kokubo K, Hirasawa R, Hishiya T, Tsuji K, Nagaoka T, Ishikawa S, Kojima A, Mito H, Hase R, Kasahara Y, Kuriyama N, Tsukamoto T, Nakamura S, Urushibara T, Kaneda S, Sakao S, Tobiume M, Suzuki Y, Tsujiwaki M, Kubo T, Hasegawa T, Nakase H, Nishida O, Takahashi K, Baba K, Iizumi Y, Okazaki T, Kimura MY, Yoshino I, Igari H, Nakajima H, Suzuki T, Hanaoka H, Nakada TA, Ikehara Y, Yokote K, Nakayama T. Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity. Proc Natl Acad Sci U S A 2022;119:e2203437119. [PMID: 35895716 DOI: 10.1073/pnas.2203437119] [Reference Citation Analysis]
|
| 47 |
Chen Y, Wang X, Chumnanvej S. Analysis of Metabonomic Characteristics after Exercise Fatigue Based on NMR. Contrast Media & Molecular Imaging 2022;2022:1-7. [DOI: 10.1155/2022/9041293] [Reference Citation Analysis]
|
| 48 |
Leung C, Su L, Simões E Silva AC. Better healthcare can reduce the risk of COVID-19 in-hospital post-partum maternal death: evidence from Brazil. Int J Epidemiol 2022;51:1733-44. [PMID: 35947762 DOI: 10.1093/ije/dyac157] [Reference Citation Analysis]
|
| 49 |
Manasova G, Artomenko V, Radchenko Y, Zhovtenko O. COVID-19 and pregnancy: epidemiology, clinical features, maternal and perinatal outcomes. A systematic review. RE 2022. [DOI: 10.18370/2309-4117.2022.65.29-37] [Reference Citation Analysis]
|
| 50 |
Luo S, Vasbinder A, Du-Fay-de-Lavallaz JM, Gomez JMD, Suboc T, Anderson E, Tekumulla A, Shadid H, Berlin H, Pan M, Azam TU, Khaleel I, Padalia K, Meloche C, O'Hayer P, Catalan T, Blakely P, Launius C, Amadi KM, Pop-Busui R, Loosen SH, Chalkias A, Tacke F, Giamarellos-Bourboulis EJ, Altintas I, Eugen-Olsen J, Williams KA, Volgman AS, Reiser J, Hayek SS; ISIC (International Study of Inflammation in COVID‐19) Group. Soluble Urokinase Plasminogen Activator Receptor and Venous Thromboembolism in COVID-19. J Am Heart Assoc 2022;:e025198. [PMID: 35924778 DOI: 10.1161/JAHA.122.025198] [Reference Citation Analysis]
|
| 51 |
Voci D, Zbinden S, Micieli E, Kucher N, Barco S. Fixed-Dose Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Pulmonary Embolism Associated with COVID-19. Viruses 2022;14:1606. [PMID: 35893672 DOI: 10.3390/v14081606] [Reference Citation Analysis]
|
| 52 |
Luijten D, de Jong CMM, Ninaber MK, Spruit MA, Huisman MV, Klok FA. Post-Pulmonary Embolism Syndrome and Functional Outcomes after Acute Pulmonary Embolism. Semin Thromb Hemost 2022. [PMID: 35820428 DOI: 10.1055/s-0042-1749659] [Reference Citation Analysis]
|
| 53 |
Bitsadze VO, Khizroeva JK, Gris J, Schulman S, Shkoda AS, Tretyakova MV, Makatsariya NA, Slukhanchuk EV, Pankratyeva LL, Petrovskiy MI, Mashechkin IV, Blinov DV, Tsibizova VI, Gadaeva ZK, Panshin SS, Samburova NV, Makatsariya AD. Pathogenetic and prognostic significance of inflammation and altered ADAMTS-13/vWF axis in patients with severe COVID-19. Akušerstvo, ginekologiâ i reprodukciâ 2022;16:228-243. [DOI: 10.17749/2313-7347/ob.gyn.rep.2022.327] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 54 |
Lee Y, Jehangir Q, Lin CH, Li P, Sule AA, Poisson L, Balijepally V, Halabi AR, Patel K, Krishnamoorthy G, Nair GB. 3D-PAST: Risk Assessment Model for Predicting Venous Thromboembolism in COVID-19. J Clin Med 2022;11. [PMID: 35887713 DOI: 10.3390/jcm11143949] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 55 |
Shapovalov AS, Kebriakov AV, Gamzatov TK, Svetlikov AV, Gorbunov GN, Kashchenko VA, Ratnikov VA. The management of COVID-associated thrombosis by local arterial thrombolysis. Regional blood circulation and microcirculation 2022;21:80-85. [DOI: 10.24884/1682-6655-2022-21-2-80-85] [Reference Citation Analysis]
|
| 56 |
Yong S, Halim A, Halim M, Al Mutair A, Alhumaid S, Al-sihati J, Albayat H, Alsaeed M, Garout M, Al Azmi R, Aldakheel N, Alshukairi AN, Al Ali HA, Almoumen AA, Rabaan AA. Rare Adverse Events Associated with BNT162b2 mRNA Vaccine (Pfizer-BioNTech): A Review of Large-Scale, Controlled Surveillance Studies. Vaccines 2022;10:1067. [DOI: 10.3390/vaccines10071067] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 57 |
Karki D, Gurung R, Nepali P, Kaphle HP, Subedi B, Adhikari S. Raised D-dimer among Admitted COVID-19 Patients in a Tertiary Care Centre: A Descriptive Cross-sectional Study. JNMA J Nepal Med Assoc 2022;60:596-9. [PMID: 36705193 DOI: 10.31729/jnma.7579] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 58 |
Kloka JA, Blum LV, Old O, Zacharowski K, Friedrichson B. Characteristics and mortality of 561,379 hospitalized COVID-19 patients in Germany until December 2021 based on real-life data. Sci Rep 2022;12:11116. [PMID: 35778464 DOI: 10.1038/s41598-022-15287-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 59 |
Takemura M, Yamaguchi M, Kobayashi M, Sumitomo T, Hirose Y, Okuzaki D, Ono M, Motooka D, Goto K, Nakata M, Uzawa N, Kawabata S. Pneumococcal BgaA Promotes Host Organ Bleeding and Coagulation in a Mouse Sepsis Model. Front Cell Infect Microbiol 2022;12:844000. [DOI: 10.3389/fcimb.2022.844000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 60 |
Sansone NMS, Boschiero MN, Marson FAL. Epidemiologic Profile of Severe Acute Respiratory Infection in Brazil During the COVID-19 Pandemic: An Epidemiological Study. Front Microbiol 2022;13:911036. [DOI: 10.3389/fmicb.2022.911036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 61 |
Salgüero Fernández S, Gabriel Medina P, Almería Lafuente A, Ballesteros Vizoso MA, Zamora Trillo A, Casals Mercadal G, Solé Enrech G, Lalana Garcés M, Guerra Ruiz AR, Ortiz Pastor O, Morales Ruiz M. Infección por SARS-CoV-2 y su impacto en la enfermedad hepática. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2022;3:134-141. [DOI: 10.1515/almed-2022-0010] [Reference Citation Analysis]
|
| 62 |
Salgüero Fernández S, Gabriel Medina P, Almería Lafuente A, Ballesteros Vizoso MA, Zamora Trillo A, Casals Mercadal G, Solé Enrech G, Lalana Garcés M, Guerra Ruiz AR, Ortiz Pastor O, Morales Ruiz M. Impact of SARS-CoV-2 infection on liver disease. Advances in Laboratory Medicine / Avances en Medicina de Laboratorio 2022;3:126-133. [DOI: 10.1515/almed-2022-0037] [Reference Citation Analysis]
|
| 63 |
Beyls C, Ghesquières T, Hermida A, Booz T, Crombet M, Martin N, Huette P, Jounieaux V, Dupont H, Abou-Arab O, Mahjoub Y. Feasibility, Prediction and Association of Right Ventricular Free Wall Longitudinal Strain with 30-Day Mortality in Severe COVID-19 Pneumonia: A Prospective Study. J Clin Med 2022;11. [PMID: 35806914 DOI: 10.3390/jcm11133629] [Reference Citation Analysis]
|
| 64 |
Patel N, Dahman B, Bajaj JS. Development of New Mental and Physical Health Sequelae among US Veterans after COVID-19. J Clin Med 2022;11. [PMID: 35743461 DOI: 10.3390/jcm11123390] [Reference Citation Analysis]
|
| 65 |
Legebeke J, Lord J, Penrice-Randal R, Vallejo AF, Poole S, Brendish NJ, Dong X, Hartley C, Holloway JW, Lucas JS, Williams AP, Wheway G, Strazzeri F, Gardner A, Schofield JPR, Skipp PJ, Hiscox JA, Polak ME, Clark TW, Baralle D. Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19. Front Immunol 2022;13:853265. [PMID: 35663963 DOI: 10.3389/fimmu.2022.853265] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 66 |
Cheung CL, Ho SC, Krishnamoorthy S, Li GH. COVID-19 and platelet traits: A bidirectional Mendelian randomization study. J Med Virol 2022. [PMID: 35676178 DOI: 10.1002/jmv.27920] [Reference Citation Analysis]
|
| 67 |
Hosoya M, Minami A, Nishiyama T, Tsuzuki N, Wakabayashi T, Oishi N. A rare case of external ear canal stenosis caused by COVID-19-related arterial thrombosis. Ear Nose Throat J 2022;:1455613221097198. [PMID: 35656821 DOI: 10.1177/01455613221097198] [Reference Citation Analysis]
|
| 68 |
Mohammed RN, Tamjidifar R, Rahman HS, Adili A, Ghoreishizadeh S, Saeedi H, Thangavelu L, Shomali N, Aslaminabad R, Marofi F, Tahavvori M, Danishna S, Akbari M, Ercan G. A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19). Cell Commun Signal 2022;20. [DOI: 10.1186/s12964-022-00856-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 69 |
Al Helali S, Sandokji H, Al Moughari A, Al Ghamdi H, Assiri T, Al Amri H. Successful use of ultraslow thrombolytic therapy in stuck mechanical aortic valve in a patient with COVID-19; a case report. International Journal of Surgery Case Reports 2022;95:107233. [DOI: 10.1016/j.ijscr.2022.107233] [Reference Citation Analysis]
|
| 70 |
Brito-Dellan N, Tsoukalas N, Font C. Thrombosis, cancer, and COVID-19. Support Care Cancer 2022. [PMID: 35567609 DOI: 10.1007/s00520-022-07098-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 71 |
Zibaeenezhad MJ, Moaref A, Abtahi F, Moghadami M, Johari MK, Ardekani A, Keshavarz M. Left ventricular thrombosis and endogenous endophthalmitis in the setting of COVID‐19: A case report. Clinical Case Reports 2022;10. [DOI: 10.1002/ccr3.5821] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 72 |
Niculae C, Anghel A, Militaru E, Tîrlescu L, Lazar M, Hristea A. Acute Pulmonary Artery Thrombosis despite Anticoagulation in Patients with COVID-19 Pneumonia: A Single-Center Retrospective Cohort Study. JCM 2022;11:2633. [DOI: 10.3390/jcm11092633] [Reference Citation Analysis]
|
| 73 |
Khanna AK, Khanna D. Venous Thromboembolism and COVID-19-an Epidemiological Perspective. Indian J Surg 2022;:1-8. [PMID: 35529246 DOI: 10.1007/s12262-022-03423-2] [Reference Citation Analysis]
|
| 74 |
Fayyad D, Kelts JL, Nielson TH, Epelle IL, Monear NC, Strawn MTG, Woerner BN, Xhabija B. COVID-19: A Systematic Review of the Transmissibility, Pathogenesis, Entry Factors, and Signature Immune Response. BioChem 2022;2:115-144. [DOI: 10.3390/biochem2020009] [Reference Citation Analysis]
|
| 75 |
Alarabi AB, Mohsen A, Mizuguchi K, Alshbool FZ, Khasawneh FT. Co-expression analysis to identify key modules and hub genes associated with COVID-19 in platelets. BMC Med Genomics 2022;15. [DOI: 10.1186/s12920-022-01222-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 76 |
Giryes S, Bragazzi NL, Bridgewood C, De Marco G, McGonagle D. COVID-19 Vasculitis and vasculopathy-Distinct immunopathology emerging from the close juxtaposition of Type II Pneumocytes and Pulmonary Endothelial Cells. Semin Immunopathol 2022. [PMID: 35412072 DOI: 10.1007/s00281-022-00928-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 77 |
Saunders LC, Collier GJ, Chan H, Hughes PJC, Smith LJ, Watson J, Meiring J, Gabriel Z, Newman T, Plowright M, Wade P, Eaden JA, Bray J, Marshall H, Capener DJ, Armstrong L, Rodgers J, Brook M, Biancardi AM, Rao MR, Norquay G, Rodgers O, Munro R, Ball JE, Stewart NJ, Lawrie A, Jenkins G, Grist J, Gleeson F, Schulte RF, Johnson KM, Wilson F, Cahn A, Swift AJ, Rajaram S, Mills GH, Watson L, Collini PJ, Lawson R, Thompson AAR, Wild JM. Longitudinal lung function assessment of patients hospitalised with COVID-19 using 1H and 129Xe lung MRI.. [DOI: 10.1101/2022.04.06.22272747] [Reference Citation Analysis]
|
| 78 |
Shepherd TD, Niaz TS, Yadav R. Massive pulmonary embolism treated with low-dose thrombolysis on the geriatric ward during the COVID-19 pandemic. BMJ Case Rep 2022;15:e248125. [PMID: 35387790 DOI: 10.1136/bcr-2021-248125] [Reference Citation Analysis]
|
| 79 |
Gallo CG, Fiorino S, Posabella G, Antonacci D, Tropeano A, Pausini E, Pausini C, Guarniero T, Hong W, Giampieri E, Corazza I, Loiacono R, Loggi E, de Biase D, Zippi M, Lari F, Zancanaro M. The function of specialized pro-resolving endogenous lipid mediators, vitamins, and other micronutrients in the control of the inflammatory processes: Possible role in patients with SARS-CoV-2 related infection. Prostaglandins Other Lipid Mediat 2022;159:106619. [PMID: 35032665 DOI: 10.1016/j.prostaglandins.2022.106619] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 80 |
Wang LL, Yang JW, Xu JF. Severe acute respiratory syndrome coronavirus 2 causes lung inflammation and injury. Clin Microbiol Infect 2022;28:513-20. [PMID: 34861410 DOI: 10.1016/j.cmi.2021.11.022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 81 |
Miękisiak G, Pettersson SD, Szarek D, Morasiewicz P, Fercho J, Adamski S, Kipiński L, Szmuda T. Acute Stroke Care during COVID-19: National Data. Infectious Disease Reports 2022;14:198-204. [DOI: 10.3390/idr14020024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 82 |
Elboushi A, Syed A, Pasenidou K, Elmi L, Keen I, Heining C, Vasudev A, Tulmuntiha S, Karia K, Ramesh P, Pearce SR, Gao-Smith F, Veenith T, Nasr H, Sam R, Juszczak M. Arterial and venous thromboembolism in critically ill, COVID 19 positive patients admitted to Intensive Care Unit. Ann Vasc Surg 2022:S0890-5096(22)00065-6. [PMID: 35257911 DOI: 10.1016/j.avsg.2022.02.005] [Reference Citation Analysis]
|
| 83 |
Reyad KA, Abelhalim MM, Tallal RE. Prevalence of Deep Venous Thrombosis in Abdominoplasty Patients after COVID-19 Convalescence: An Alarming Flag. Plastic and Reconstructive Surgery - Global Open 2022;10:e4196. [DOI: 10.1097/gox.0000000000004196] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 84 |
Chen L, Qu J, Kalyani FS, Zhang Q, Fan L, Fang Y, Li Y, Xiang C. Mesenchymal stem cell-based treatments for COVID-19: status and future perspectives for clinical applications. Cell Mol Life Sci 2022;79. [DOI: 10.1007/s00018-021-04096-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 85 |
Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J 2022;479:537-59. [PMID: 35195253 DOI: 10.1042/BCJ20220016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 27.0] [Reference Citation Analysis]
|
| 86 |
Onishi T, Shimonishi N, Takeyama M, Furukawa S, Ogiwara K, Nakajima Y, Kasahara K, Nishio K, Yoshimoto K, Inoue S, Kawaguchi M, Fukushima H, Saito Y, Yoshiji H, Muro S, Tsuruya K, Okada S, Sugie K, Kawaguchi R, Nishikubo T, Yamazaki M, Oda Y, Kawabe T, Onishi K, Nishio T, Nogami K. The balance of comprehensive coagulation and fibrinolytic potential is disrupted in patients with moderate to severe COVID-19. Int J Hematol 2022. [PMID: 35171446 DOI: 10.1007/s12185-022-03308-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 87 |
Gangadharan S, Parker S, Ahmed FW. Chest radiological finding of COVID-19 in patients with and without diabetes mellitus: Differences in imaging finding. World J Radiol 2022; 14(1): 13-18 [DOI: 10.4329/wjr.v14.i1.13] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 88 |
Ihnatko M, Truchla I, Ihnatková L, Prohászka Z, Lazúrová I. Case Report: A Case of COVID Vaccine-Induced Thrombotic Thrombocytopenia Manifested as Pulmonary Embolism and Hemorrhagia. A First Reported Case From Slovakia. Front Med (Lausanne) 2021;8:789972. [PMID: 35059416 DOI: 10.3389/fmed.2021.789972] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 89 |
Dalpiaz G, Gamberini L, Carnevale A, Spadaro S, Mazzoli CA, Piciucchi S, Allegri D, Capozzi C, Neziri E, Bartolucci M, Muratore F, Coppola F, Poerio A, Giampalma E, Baldini L, Tonetti T, Cappellini I, Colombo D, Zani G, Mellini L, Agnoletti V, Damiani F, Gordini G, Laici C, Gola G, Potalivo A, Montomoli J, Ranieri VM, Russo E, Taddei S, Volta CA, Scaramuzzo G. Clinical implications of microvascular CT scan signs in COVID-19 patients requiring invasive mechanical ventilation. Radiol Med 2022. [PMID: 35034320 DOI: 10.1007/s11547-021-01444-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 90 |
Wieteska-miłek M, Kurzyna M. Thromboembolic Events in COVID-19. Contemporary Cardiology 2022. [DOI: 10.1007/978-3-031-15478-2_12] [Reference Citation Analysis]
|
| 91 |
Chakraborty D, Mondal P, Sundar K, Dingal S. Is COVID-19 infection also a silent killer?: A case of acute stroke. J Prim Care Spec 2022;3:40. [DOI: 10.4103/jopcs.jopcs_2_22] [Reference Citation Analysis]
|
| 92 |
Assandri R. Laboratory Markers of COVID-19 in the Emergency Room. Biomarkers in Trauma, Injury and Critical Care 2022. [DOI: 10.1007/978-3-030-87302-8_41-1] [Reference Citation Analysis]
|
| 93 |
Rupesh KA, Venkateswarlu M, Pamujula S, Kalyankar PP, Salvi NM, Vora S. A Study on Chronofatality Trends of COVID-19 Deaths at a Tertiary Care Hospital. Chronobiol Med 2021;3:163-166. [DOI: 10.33069/cim.2021.0024] [Reference Citation Analysis]
|
| 94 |
Aydin S, Ugur K, Yalcin H, Sahin İ, Akkoc RF, Yakar B, Yucel D, Aydin S. Overview of COVID-19’s relationship with thrombophilia proteins. Turkish Journal of Biochemistry 2021;46:609-622. [DOI: 10.1515/tjb-2021-0183] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 95 |
Gauchel N, Krauel K, Hamad MA, Bode C, Duerschmied D. Thromboinflammation as a Driver of Venous Thromboembolism. Hamostaseologie 2021;41:428-32. [PMID: 34942655 DOI: 10.1055/a-1661-0257] [Reference Citation Analysis]
|
| 96 |
Gaughan E, Sethi T, Quinn T, Hirani N, Mills A, Bruce AM, Mackinnon A, Aslanis V, Li F, O’connor R, Parker RA, Norrie J, Dear J, Akram AR, Koch O, Wang-jairaj J, Slack RJ, Gravelle L, Lindmark B, Dhaliwal K. GB0139, an inhaled small molecule inhibitor of galectin-3, in COVID-19 pneumonitis: a randomised, controlled, open-label, phase 2a experimental medicine trial of safety, pharmacokinetics, and potential therapeutic value.. [DOI: 10.1101/2021.12.21.21267983] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 97 |
Saidov MZ. Pathogenetic value of cell infiltrate in immunoinflammatory rheumatic diseases. Med immunol 2021;23:1239-1270. [DOI: 10.15789/1563-0625-pvo-2386] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 98 |
Emadi-Baygi M, Ehsanifard M, Afrashtehpour N, Norouzi M, Joz-Abbasalian Z. Corona Virus Disease 2019 (COVID-19) as a System-Level Infectious Disease With Distinct Sex Disparities. Front Immunol 2021;12:778913. [PMID: 34912345 DOI: 10.3389/fimmu.2021.778913] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 99 |
Gonçalves FAR, Besen BAMP, Lima CA, Corá AP, Pereira AJR, Perazzio SF, Gouvea CP, Fonseca LAM, Trindade EM, Sumita NM, Duarte AJDS, Lichtenstein A, Bonfa E, Utiyama EM, Segurado AC, Perondi B, Miethke-Morais A, Montal AC, Harima L, Fusco SRG, Silva MF, Rocha MC, Marcilio I, Rios IC, Kawano FYO, Jesus MA, Kallas ÉG, Carmo C, Tanaka C, Souza HP, Marchini JFM, Carvalho C, Ferreira JC, Levin ASS, Oliveira MS, Guimarães T, Lázari CDS, Sabino E, Magri MMC, Barros-Filho TEP, Francisco MCPB, Costa SF; HCFMUSP COVID-19 Study Group. Use and misuse of biomarkers and the role of D-dimer and C-reactive protein in the management of COVID-19: A post-hoc analysis of a prospective cohort study. Clinics (Sao Paulo) 2021;76:e3547. [PMID: 34909913 DOI: 10.6061/clinics/2021/e3547] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 100 |
Ouarradi AE, Bensahi I, Alaammari I, Haoudar A, Dini N, Sabry M. [Thromboembolic complications in children during COVID-19]. Pan Afr Med J 2021;40:137. [PMID: 34909105 DOI: 10.11604/pamj.2021.40.137.31979] [Reference Citation Analysis]
|
| 101 |
Zhou X, Cheng Z, Hu Y. COVID-19 and Venous Thromboembolism: From Pathological Mechanisms to Clinical Management. J Pers Med 2021;11:1328. [PMID: 34945800 DOI: 10.3390/jpm11121328] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 102 |
Knight R, Walker V, Ip S, Cooper JA, Bolton T, Keene S, Denholm R, Akbari A, Abbasizanjani H, Torabi F, Omigie E, Hollings S, North T, Toms R, Di Angelantonio E, Denaxas S, Thygesen JH, Tomlinson C, Bray B, Smith CJ, Barber M, Smith GD, Chaturvedi N, Sudlow C, Whiteley WN, Wood A, Sterne JAC, for the CVD-COVID-UK/COVID-IMPACT consortium and the Longitudinal Health and Wellbeing COVID-19 National Core Study. Association of COVID-19 with arterial and venous vascular diseases: a population-wide cohort study of 48 million adults in England and Wales.. [DOI: 10.1101/2021.11.22.21266512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 103 |
Soy M, Keser G, Atagündüz P. Pathogenesis and treatment of cytokine storm in COVID-19. Turk J Biol 2021;45:372-89. [PMID: 34803441 DOI: 10.3906/biy-2105-37] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 104 |
Beran J, Špajdel M, Slíva J. Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course. Viruses 2021;13:2246. [PMID: 34835052 DOI: 10.3390/v13112246] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
|
| 105 |
Qureshi AI. Updated Perspective on Severe Acute Respiratory Syndrome Coronavirus-2 Infection and Ischemic Stroke. Stroke 2021;52:3987-8. [PMID: 34732069 DOI: 10.1161/STROKEAHA.121.037010] [Reference Citation Analysis]
|
| 106 |
Takahashi T, Schleimer RP. Epithelial-Cell-Derived Extracellular Vesicles in Pathophysiology of Epithelial Injury and Repair in Chronic Rhinosinusitis: Connecting Immunology in Research Lab to Biomarkers in Clinics. Int J Mol Sci 2021;22:11709. [PMID: 34769139 DOI: 10.3390/ijms222111709] [Reference Citation Analysis]
|
| 107 |
Watts I, Smith D, Mounter S, Baker EH, Hitchings AW, Gill D. A case series of vaccine-induced thrombotic thrombocytopenia in a London teaching hospital. Br J Clin Pharmacol 2021. [PMID: 34694650 DOI: 10.1111/bcp.15116] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 108 |
Ahmad F, Kannan M, Ansari AW. Role of SARS-CoV-2 -induced cytokines and growth factors in coagulopathy and thromboembolism. Cytokine Growth Factor Rev 2021:S1359-6101(21)00079-4. [PMID: 34750061 DOI: 10.1016/j.cytogfr.2021.10.007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 109 |
Landau N, Shoenfeld Y, Negru L, Segal G. Exploring the pathways of inflammation and coagulopathy in COVID-19: A narrative tour into a viral rabbit hole. Int Rev Immunol 2021;:1-9. [PMID: 34678120 DOI: 10.1080/08830185.2021.1993211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 110 |
Festoff BW, Dockendorff C. The Evolving Concept of Neuro-Thromboinflammation for Neurodegenerative Disorders and Neurotrauma: A Rationale for PAR1-Targeting Therapies. Biomolecules 2021;11:1558. [PMID: 34827556 DOI: 10.3390/biom11111558] [Reference Citation Analysis]
|
| 111 |
Tan LY, Komarasamy TV, Rmt Balasubramaniam V. Hyperinflammatory Immune Response and COVID-19: A Double Edged Sword. Front Immunol 2021;12:742941. [PMID: 34659238 DOI: 10.3389/fimmu.2021.742941] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 12.0] [Reference Citation Analysis]
|
| 112 |
Santosa YP, Yuwono A. Two Different Clinical Presentations of Acute Limb Ischemia Caused by Acute Thrombotic Events in COVID-19. Cureus 2021;13:e17916. [PMID: 34660110 DOI: 10.7759/cureus.17916] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 113 |
Wang J, Hajizadeh N, Shore-Lesserson L. The Value of Thromboelastography (TEG) in COVID-19 Critical Illness as Illustrated by a Case Series. J Cardiothorac Vasc Anesth 2021:S1053-0770(21)00934-4. [PMID: 34802831 DOI: 10.1053/j.jvca.2021.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 114 |
Newman J, Boubriak I, Jenkins D, Ng C, Ruggiero A, Screaton N, Cannon J, Toshner M. Rising COVID-19 related acute pulmonary emboli but falling national chronic thromboembolic pulmonary hypertension referrals from a large national dataset. ERJ Open Res 2021;7:00431-2021. [PMID: 34646880 DOI: 10.1183/23120541.00431-2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 115 |
Patil P, Shetty P, Kuriakose N, Gollapalli P, Shetty S, Bhandary R, Vishwanatha JK, Ghate SD. Molecular Insights on the Possible Role of Annexin A2 in COVID-19 Pathogenesis and Post-Infection Complications. Int J Mol Sci 2021;22:11028. [PMID: 34681689 DOI: 10.3390/ijms222011028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 116 |
Murphy CA, O'Reilly DP, Edebiri O, Weiss L, Cullivan S, El-Khuffash A, Doyle E, Donnelly JC, Malone FD, Ferguson W, Drew RJ, O'Loughlin J, Neary E, Maguire PB, Kevane B, NíAinle F, McCallion N. Haematological parameters and coagulation in umbilical cord blood following COVID-19 infection in pregnancy. Eur J Obstet Gynecol Reprod Biol 2021;266:99-105. [PMID: 34601263 DOI: 10.1016/j.ejogrb.2021.09.019] [Reference Citation Analysis]
|
| 117 |
Kreidieh F, Temraz S. Anticoagulation for COVID-19 Patients: A Bird's-Eye View. Clin Appl Thromb Hemost 2021;27:10760296211039288. [PMID: 34595937 DOI: 10.1177/10760296211039288] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 118 |
Cronin JN, Camporota L, Formenti F. Mechanical ventilation in COVID-19: A physiological perspective. Exp Physiol 2021. [PMID: 34541721 DOI: 10.1113/EP089400] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 119 |
Arachchillage DJ, Rajakaruna I, Odho Z, Crossette-Thambiah C, Nicolson PLR, Roberts LN, Allan C, Lewis S, Riat R, Mounter P, Lynch C, Langridge A, Oakes R, Aung N, Drebes A, Dutt T, Raheja P, Delaney A, Essex S, Lowe G, Sutton D, Lentaigne C, Sayar Z, Kilner M, Everington T, Shapiro S, Alikhan R, Szydlo R, Makris M, Laffan M. Clinical outcomes and the impact of prior oral anticoagulant use in patients with coronavirus disease 2019 admitted to hospitals in the UK - a multicentre observational study. Br J Haematol 2021. [PMID: 34500500 DOI: 10.1111/bjh.17787] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 120 |
Alarabi AB, Mohsen A, Mizuguchi K, Alshbool FZ, Khasawneh FT. Co-expression analysis to identify key modules and hub genes associated with COVID19 in Platelets.. [DOI: 10.1101/2021.09.01.458644] [Reference Citation Analysis]
|
| 121 |
Daisley H Jr, Rampersad A, Daisley M, Ramdin A, Acco O, Narinesingh F, Humphrey O, James E. The vasa vasorum of the large pulmonary vessels are involved in COVID-19. Autops Case Rep 2021;11:e2021304. [PMID: 34458172 DOI: 10.4322/acr.2021.304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 122 |
Paidas MJ, Mohamed AB, Norenberg MD, Saad A, Barry AF, Colon C, Kenyon NS, Jayakumar AR. Multi-Organ Histopathological Changes in a Mouse Hepatitis Virus Model of COVID-19. Viruses 2021;13:1703. [PMID: 34578284 DOI: 10.3390/v13091703] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 123 |
Xiang Y, Feng Y, Qiu J, So H. Association of COVID-19 vaccination with risks of hospitalization due to cardiovascular and other diseases: A study of the UK Biobank.. [DOI: 10.1101/2021.08.15.21262097] [Reference Citation Analysis]
|
| 124 |
Zhang J, Gao XL, Yang LH. [Research progress in coagulation dysfunction and its relationship with cytokine storm syndrome in patients with severe/critical COVID-19]. Zhonghua Xue Ye Xue Za Zhi 2021;42:700-4. [PMID: 34547883 DOI: 10.3760/cma.j.issn.0253-2727.2021.08.019] [Reference Citation Analysis]
|
| 125 |
Calvisi SL, Ramirez GA, Scavini M, Da Prat V, Di Lucca G, Laurenzi A, Gallina G, Cavallo L, Borio G, Farolfi F, Pascali M, Castellani J, Lampasona V, D'Angelo A, Landoni G, Ciceri F, Querini PR, Tresoldi M, Piemonti L. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19. Metabolism 2021;123:154845. [PMID: 34364927 DOI: 10.1016/j.metabol.2021.154845] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 126 |
Morris G, Bortolasci CC, Puri BK, Marx W, O'Neil A, Athan E, Walder K, Berk M, Olive L, Carvalho AF, Maes M. The cytokine storms of COVID-19, H1N1 influenza, CRS and MAS compared. Can one sized treatment fit all? Cytokine 2021;144:155593. [PMID: 34074585 DOI: 10.1016/j.cyto.2021.155593] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 17.5] [Reference Citation Analysis]
|
| 127 |
Clarke KM, Riga V, Shirodkar AL, Meyer J. Proning related bilateral anterior ischaemic optic neuropathy in a patient with COVID-19 related acute respiratory distress syndrome. BMC Ophthalmol 2021;21:276. [PMID: 34256728 DOI: 10.1186/s12886-021-02028-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 128 |
Koenis DS, Beegun I, Jouvene CC, Aguirre GA, Souza PR, Gonzalez-Nunez M, Ly L, Pistorius K, Kocher HM, Ricketts W, Thomas G, Perretti M, Alusi G, Pfeffer P, Dalli J. Disrupted Resolution Mechanisms Favor Altered Phagocyte Responses in COVID-19. Circ Res 2021;129:e54-71. [PMID: 34238021 DOI: 10.1161/CIRCRESAHA.121.319142] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 129 |
O'Gallagher K, Shek A, Bean DM, Bendayan R, Papachristidis A, Teo JTH, Dobson RJB, Shah AM, Zakeri R. Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19. BMC Cardiovasc Disord 2021;21:327. [PMID: 34217220 DOI: 10.1186/s12872-021-02137-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 130 |
Klepikov I. COVID-19 Pandemic: The Causative Agent is New, The Problem is Old. IJCV 2021;3:14-19. [DOI: 10.14302/issn.2692-1537.ijcv-21-3626] [Reference Citation Analysis]
|
| 131 |
Wachowska M, Kilarski WW. Lymphatics regulation of the inflammatory clotting creates the natural on-off switch for the immune ignorance that allows subcutaneous allografting.. [DOI: 10.1101/2021.06.22.449446] [Reference Citation Analysis]
|
| 132 |
European Society of Intensive Care Medicine (ESICM)., Global Sepsis Alliance (GSA)., Society of Critical Care Medicine (SCCM). Reducing the global burden of sepsis: a positive legacy for the COVID-19 pandemic? Intensive Care Med 2021;47:733-6. [PMID: 34132841 DOI: 10.1007/s00134-021-06409-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 133 |
Parker K, Hamilton P, Hanumapura P, Castelino L, Murphy M, Challiner R, Thachil J, Ebah L. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients. BMC Nephrol 2021;22:224. [PMID: 34134645 DOI: 10.1186/s12882-021-02436-5] [Reference Citation Analysis]
|
| 134 |
Kvietys PR, Fakhoury HMA, Kadan S, Yaqinuddin A, Al-Mutairy E, Al-Kattan K. COVID-19: Lung-Centric Immunothrombosis. Front Cell Infect Microbiol 2021;11:679878. [PMID: 34178722 DOI: 10.3389/fcimb.2021.679878] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 135 |
Zhang J, Huang X, Ding D, Tao Z. Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases. Exp Hematol Oncol 2021;10:34. [PMID: 34059141 DOI: 10.1186/s40164-021-00228-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 136 |
Sridhar S, Nicholls J. Pathophysiology of infection with SARS-CoV-2-What is known and what remains a mystery. Respirology 2021;26:652-65. [PMID: 34041821 DOI: 10.1111/resp.14091] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 137 |
Alfarouk KO, AlHoufie STS, Ahmed SBM, Shabana M, Ahmed A, Alqahtani SS, Alqahtani AS, Alqahtani AM, Ramadan AM, Ahmed ME, Ali HS, Bashir A, Devesa J, Cardone RA, Ibrahim ME, Schwartz L, Reshkin SJ. Pathogenesis and Management of COVID-19. J Xenobiot 2021;11:77-93. [PMID: 34063739 DOI: 10.3390/jox11020006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 138 |
Legebeke J, Lord J, Penrice-randal R, Vallejo AF, Poole S, Brendish NJ, Dong X, Hartley C, Holloway JW, Lucas JS, Williams AP, Wheway G, Strazzeri F, Gardner A, Schofield JP, Skipp PJ, Hiscox JA, Polak ME, Clark TW, Baralle D. Distinct immune responses in patients infected with influenza or SARS-CoV-2, and in COVID-19 survivors, characterised by transcriptomic and cellular abundance differences in blood.. [DOI: 10.1101/2021.05.12.21257086] [Reference Citation Analysis]
|
| 139 |
Kohansal Vajari M, Shirin M, Pourbagheri-Sigaroodi A, Akbari ME, Abolghasemi H, Bashash D. COVID-19-related coagulopathy: A review of pathophysiology and pharmaceutical management. Cell Biol Int 2021. [PMID: 33945651 DOI: 10.1002/cbin.11623] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 140 |
Dixit NM, Churchill A, Nsair A, Hsu JJ. Post-Acute COVID-19 Syndrome and the cardiovascular system: What is known? Am Heart J Plus 2021;5:100025. [PMID: 34192289 DOI: 10.1016/j.ahjo.2021.100025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 31] [Article Influence: 11.5] [Reference Citation Analysis]
|
| 141 |
Igor K. Psychoanalysis of the doctrine of acute pneumonia. Int J Clin Microbiol Biochem Technol 2021;4:032-036. [DOI: 10.29328/journal.ijcmbt.1001023] [Reference Citation Analysis]
|
| 142 |
Grover P, Gulati S. Highlights from the American society of hematology conference 2020. J Thromb Thrombolysis 2021;52:354-62. [PMID: 33900522 DOI: 10.1007/s11239-021-02449-9] [Reference Citation Analysis]
|
| 143 |
Calvisi SL, Ramirez GA, Scavini M, Da Prat V, Di Lucca G, Laurenzi A, Gallina G, Cavallo L, Borio G, Farolfi F, Pascali M, Castellani J, Lampasona V, D’angelo A, Landoni G, Ciceri F, Querini PR, Tresoldi M, Piemonti L. Thromboembolism risk among patients with diabetes/stress hyperglycemia and COVID-19.. [DOI: 10.1101/2021.04.17.21255540] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 144 |
Khurram R, Naidu V, Butt MF, Durnford L, Joffe M. Superior ophthalmic vein thrombosis secondary to COVID-19: an index case. Radiol Case Rep 2021;16:1138-43. [PMID: 33688386 DOI: 10.1016/j.radcr.2021.02.063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 145 |
Belov BS, Lila AM. COVID-19 and rheumatology: A year later. Naučno-praktičeskaâ revmatologiâ 2021;59:31-36. [DOI: 10.47360/1995-4484-2021-31-36] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 146 |
Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G. miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations. Res Sq 2021:rs. [PMID: 33564755 DOI: 10.21203/rs.3.rs-192099/v1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 147 |
Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells. Noncoding RNA 2021;7:9. [PMID: 33540664 DOI: 10.3390/ncrna7010009] [Cited by in Crossref: 11] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 148 |
Jesrani G, Arya Y, Gupta M, Syal A. COVID-19 Infection masquerading as bilateral pulmonary embolism: A rare case report and review of literature. Amrita J Med 2021;17:66. [DOI: 10.4103/amjm.amjm_22_21] [Reference Citation Analysis]
|
| 149 |
Mhlana N, Parker A, Division of General Medicine, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, South Africa, Division of Infectious Diseases, Department of Medicine, Faculty of Medicine and Health Sciences, Stellenbosch University and Tygerberg Hospital, South Africa. Current Status of Anticoagulation for Hospitalized Patients with Coronavirus Disease 2019 (COVID-19). WJCM 2021;3:125. [DOI: 10.18772/26180197.2021.v3n2a5] [Reference Citation Analysis]
|
| 150 |
Arachchillage D, Rajakaruna I, Odho Z, Crossette-thambiah C, Nicolson PLR, Roberts L, Allan C, Lewis S, Riat R, Mounter P, Lynch C, Langridge A, Oakes R, Aung N, Drebes A, Dutt T, Raheja P, Delaney A, Essex S, Lowe G, Sutton D, Lentaigne C, Sayer Z, Kilner M, Everington T, Shapiro S, Alikhan R, Szydlo R, Makris M, Laffan MA. Clinical Outcomes and the Impact of Oral Anticoagulants Prior to Diagnosis of COVID-19 on Clinical Outcomes in Patients Admitted to Hospitals in the UK – a Multicentre Observational Study. SSRN Journal. [DOI: 10.2139/ssrn.3866562] [Reference Citation Analysis]
|
| 151 |
Hoteit L, Deeb AP, Andraska EA, Kaltenmeier C, Yazdani HO, Tohme S, Neal MD, Mota RI. The Pathobiological Basis for Thrombotic Complications in COVID-19: a Review of the Literature. Curr Pathobiol Rep 2021;9:107-17. [PMID: 34900401 DOI: 10.1007/s40139-021-00228-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
